AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benedict, R. H. B.
Right arrow Articles by Bakshi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benedict, R. H. B.
Right arrow Articles by Bakshi, R.

BRAIN

Regional Lobar Atrophy Predicts Memory Impairment in Multiple Sclerosis

Ralph H. B. Benedicta,b, Robert Zivadinova,c, Dominic A. Caronea,b, Bianca Weinstock-Guttmana,b, Jeff Gainesa, Cosimo Maggiorec, Jitendra Sharmaa,b, Maria-Antonietta Tomassic and Rohit Bakshia,b,d

a Department of Neurology, SUNY Buffalo School of Medicine, Buffalo, NY
b Jacobs Neurological Institute, Buffalo, NY
c Department of Clinical Medicine and Neurology, University of Trieste, Trieste, Italy
d Center for Neurological Imaging, Harvard Medical School, Boston, MA

Address correspondence to Ralph H. B. Benedict, SUNY Buffalo School of Medicine, Department of Neurology, Buffalo General Hospital, Suite D-6 100, High Street, Buffalo, NY 14203; and Rohit Bakshi, Brigham/Women’s Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, HIM 730, Boston, MA 02115

BACKGROUND AND PURPOSE: In recent studies, measures of whole brain atrophy were strongly correlated with neuropsychological testing, explaining more variance than measures of lesion burden in patients with multiple sclerosis. The relationship between regional lobar atrophy and cognitive impairment is yet to be examined. We endeavored to assess the clinical significance of regional lobar atrophy in multiple sclerosis.

METHODS: In a cross-sectional study, we evaluated 31 patients with multiple sclerosis with brain MR imaging and neuropsychological testing. Impairment was determined by comparison with demographically matched healthy controls. MR imaging generated measures of lesion burden (fluid-attenuated inversion recovery hyperintense volume), general atrophy (brain parenchymal fraction), central atrophy (lateral ventricle volume), and lobar atrophy (regional brain parenchymal fraction of frontal, temporal, parietal, and occipital lobes in each hemisphere). Neuropsychological testing emphasized measures of processing speed and memory, because these are commonly affected in multiple sclerosis.

RESULTS: Patients with multiple sclerosis showed significant atrophy and impairment on all neuropsychological tests. Regional atrophy accounted for the most variance in all regression models predicting memory performance. Left temporal atrophy was the primary predictor of auditory/verbal memory (partial r’s = 0.55–0.61), and both left and right temporal atrophy predicted visual/spatial memory performance (partial r’s = 0.51–0.67). Models predicting learning consistency retained frontal lobe atrophy measures (partial r’s = 0.44–0.68). Central and general atrophy measures were the primary predictors in modeling processing speed (partial r’s = 0.42–0.64).

CONCLUSION: Regional atrophy accounts for more variance than lesion burden, whole brain atrophy, or lateral ventricle volume in predicting multiple sclerosis–associated memory dysfunction.




This article has been cited by other articles:


Home page
J. Neurol. Neurosurg. PsychiatryHome page
D Horakova, J L Cox, E Havrdova, S Hussein, O Dolezal, D Cookfair, M G Dwyer, Z Seidl, N Bergsland, M Vaneckova, et al.
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study
J. Neurol. Neurosurg. Psychiatry, April 1, 2008; 79(4): 407 - 414.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R. Zivadinov, L. Locatelli, D. Cookfair, B. Srinivasaraghavan, A. Bertolotto, M. Ukmar, A. Bratina, C. Maggiore, A. Bosco, A. Grop, et al.
I nterferon beta-1a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy
Multiple Sclerosis, May 1, 2007; 13(4): 490 - 501.
[Abstract] [PDF]


Home page
Arch NeurolHome page
R. H. B. Benedict, J. M. Bruce, M. G. Dwyer, N. Abdelrahman, S. Hussein, B. Weinstock-Guttman, N. Garg, F. Munschauer, and R. Zivadinov
Neocortical atrophy, third ventricular width, and cognitive dysfunction in multiple sclerosis.
Arch Neurol, September 1, 2006; 63(9): 1301 - 1306.
[Abstract] [Full Text] [PDF]


Home page
J PsychopharmacolHome page
B. B. Quednow, F. Jessen, K.-U. Kuhn, W. Maier, I. Daum, and M. Wagner
Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction
J Psychopharmacol, May 1, 2006; 20(3): 373 - 384.
[Abstract] [PDF]


Home page
NeurologyHome page
M. P. Sanfilipo, R. H.B. Benedict, B. Weinstock-Guttman, and R. Bakshi
Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis
Neurology, March 14, 2006; 66(5): 685 - 692.
[Abstract] [Full Text] [PDF]